Citigroup vs JPMorgan Chase
C and JPM side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How C and JPM compare
JPMorgan Chase is the larger company, worth 4.4 times as much as Citigroup ($896B against $206B).
On earnings, Citigroup is cheaper: it trades at 13.3× trailing earnings, against 14.4× for JPMorgan Chase.
JPMorgan Chase grew revenue faster over the last twelve months (13.5% versus 10.2% for Citigroup).
JPMorgan Chase keeps more of each dollar of sales as profit, with a net margin of 32.6% compared with 19.5% at Citigroup.
Both pay dividends: Citigroup yields 2.0% and JPMorgan Chase 1.8%.
JPMorgan Chase scores higher on the StockData Score (17 against 11 for Citigroup), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | C | JPM |
|---|---|---|
| Size and price | ||
| Market cap | $206B | $896B |
| Share price | $122.64 | $337.04 |
| Change, 1 year | 23.7% | 10.3% |
| Change, 5 years | 83.1% | 101% |
| Beta (5Y) | 1.16 | 1.01 |
| Employees | 226K | 319K |
| StockData Score | ||
| Total score | 11 | 17 (better) |
| Valuation score | 2 (better) | 0 |
| Growth score | 1 | 4 (better) |
| Performance score | 2 | 5 (better) |
| Health score | 4 | 5 (better) |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/E | 13.3× (better) | 14.4× |
| P/S | 2.3× (better) | 4.5× |
| P/B | 1.0× (better) | 2.4× |
| PEG | – | 0.79 |
| FCF yield | −11.9% | – |
| Fair value | $114.77 | $246.53 |
| Margin of safety | −6.9% (better) | −36.7% |
| Growth | ||
| Revenue growth (TTM) | 10.2% | 13.5% (better) |
| Revenue growth, 5Y average | 2.5% | 8.7% (better) |
| Net income growth (TTM) | 25.8% (better) | 15.1% |
| EPS growth (TTM) | 36.8% (better) | 19.8% |
| EPS growth, 5Y average | 8.2% | 17.7% (better) |
| Profitability | ||
| Net margin | 19.5% | 32.6% (better) |
| FCF margin | −26.8% | – |
| Return on equity | 8.4% | 17.8% (better) |
| Financial health | ||
| Debt / equity | 0.33 | 0.19 (better) |
| Altman Z-score | 0.19 | 0.28 (better) |
| Piotroski F-score | 5 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | 2.0% (better) | 1.8% |
| Payout ratio | 30.5% | 26.6% |
| Years of dividend growth | – | 15 |
| Dividend growth, 5Y average | – | 10.0% |
| Buyback yield | 9.6% (better) | 3.5% |
| Shareholder yield | 11.6% (better) | 5.4% |
| Ownership | ||
| Held by institutions | 79.8% | 74.7% |
| Held by insiders | 0.29% | 0.37% |
| Insider net buying, 12 months | −$23.0M (better) | −$126M |
| Superinvestors holding | 4 | 10 (better) |
| Short interest, % of float | 1.3% | – |
Go deeper
- C stock overview
- C income statement
- C valuation and score
- JPM stock overview
- JPM income statement
- JPM valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.